

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 6.62928526 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.43568820 |
| 3 | presynaptic membrane organization (GO:0097090) | 6.10544554 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 6.10185608 |
| 5 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.01567089 |
| 6 | neurotransmitter-gated ion channel clustering (GO:0072578) | 6.00337334 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 5.99310676 |
| 8 | vocalization behavior (GO:0071625) | 5.89439953 |
| 9 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.63843060 |
| 10 | postsynaptic membrane organization (GO:0001941) | 5.60788936 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.56539864 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.52648935 |
| 13 | glutamate secretion (GO:0014047) | 5.52177228 |
| 14 | protein localization to synapse (GO:0035418) | 5.35713751 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.17082015 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.16908372 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.13558548 |
| 18 | cerebellar granule cell differentiation (GO:0021707) | 4.84989505 |
| 19 | nucleobase catabolic process (GO:0046113) | 4.80101936 |
| 20 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.73390113 |
| 21 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.64682562 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 4.48106702 |
| 23 | response to histamine (GO:0034776) | 4.45383281 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 4.42579679 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.40353959 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 4.36461738 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.35565618 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.35494050 |
| 29 | locomotory exploration behavior (GO:0035641) | 4.32551915 |
| 30 | behavioral response to nicotine (GO:0035095) | 4.29605506 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 4.26649583 |
| 32 | long-term synaptic potentiation (GO:0060291) | 4.24658268 |
| 33 | neurotransmitter secretion (GO:0007269) | 4.17849197 |
| 34 | mechanosensory behavior (GO:0007638) | 4.17385202 |
| 35 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.14308654 |
| 36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.08798087 |
| 37 | startle response (GO:0001964) | 4.01366295 |
| 38 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.97631355 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.95051415 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.94061146 |
| 41 | synaptic vesicle maturation (GO:0016188) | 3.93392559 |
| 42 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.91704518 |
| 43 | positive regulation of synapse assembly (GO:0051965) | 3.83184397 |
| 44 | auditory behavior (GO:0031223) | 3.81826607 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.79798369 |
| 46 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.79011894 |
| 47 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.76539322 |
| 48 | regulation of synapse maturation (GO:0090128) | 3.69978747 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.66951886 |
| 50 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.66357330 |
| 51 | retinal ganglion cell axon guidance (GO:0031290) | 3.65578634 |
| 52 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.64372737 |
| 53 | regulation of neurotransmitter secretion (GO:0046928) | 3.62763536 |
| 54 | positive regulation of neurotransmitter transport (GO:0051590) | 3.62093776 |
| 55 | neurofilament cytoskeleton organization (GO:0060052) | 3.62059187 |
| 56 | central nervous system myelination (GO:0022010) | 3.54536965 |
| 57 | axon ensheathment in central nervous system (GO:0032291) | 3.54536965 |
| 58 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.53349167 |
| 59 | regulation of synaptic plasticity (GO:0048167) | 3.51820917 |
| 60 | limb bud formation (GO:0060174) | 3.49912495 |
| 61 | exploration behavior (GO:0035640) | 3.48725418 |
| 62 | regulation of glutamate secretion (GO:0014048) | 3.48408854 |
| 63 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.46862130 |
| 64 | behavioral response to cocaine (GO:0048148) | 3.45167483 |
| 65 | neuron recognition (GO:0008038) | 3.41107843 |
| 66 | transferrin transport (GO:0033572) | 3.39795958 |
| 67 | neurotransmitter transport (GO:0006836) | 3.39213578 |
| 68 | positive regulation of synaptic transmission (GO:0050806) | 3.31538410 |
| 69 | nonmotile primary cilium assembly (GO:0035058) | 3.30008199 |
| 70 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.28907213 |
| 71 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.28907213 |
| 72 | female mating behavior (GO:0060180) | 3.28771915 |
| 73 | regulation of female receptivity (GO:0045924) | 3.28493138 |
| 74 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.27719834 |
| 75 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.27332801 |
| 76 | regulation of neurotransmitter transport (GO:0051588) | 3.25845037 |
| 77 | regulation of synapse assembly (GO:0051963) | 3.25466589 |
| 78 | synaptic vesicle endocytosis (GO:0048488) | 3.23228995 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 3.20715059 |
| 80 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.17986351 |
| 81 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.17643738 |
| 82 | membrane depolarization (GO:0051899) | 3.17490151 |
| 83 | ferric iron transport (GO:0015682) | 3.16521477 |
| 84 | trivalent inorganic cation transport (GO:0072512) | 3.16521477 |
| 85 | membrane assembly (GO:0071709) | 3.16229111 |
| 86 | long-term memory (GO:0007616) | 3.15985381 |
| 87 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.15548747 |
| 88 | synapse assembly (GO:0007416) | 3.14388398 |
| 89 | cell proliferation in forebrain (GO:0021846) | 3.12983513 |
| 90 | serotonin metabolic process (GO:0042428) | 3.11266075 |
| 91 | response to auditory stimulus (GO:0010996) | 3.10813426 |
| 92 | regulation of neurotransmitter levels (GO:0001505) | 3.10397896 |
| 93 | behavioral fear response (GO:0001662) | 3.10350014 |
| 94 | behavioral defense response (GO:0002209) | 3.10350014 |
| 95 | spinal cord development (GO:0021510) | 3.08761894 |
| 96 | learning (GO:0007612) | 3.05971517 |
| 97 | neurotransmitter uptake (GO:0001504) | 3.05469737 |
| 98 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.05426072 |
| 99 | membrane hyperpolarization (GO:0060081) | 3.05295874 |
| 100 | transmission of nerve impulse (GO:0019226) | 3.03935993 |
| 101 | establishment of mitochondrion localization (GO:0051654) | 3.02567584 |
| 102 | fear response (GO:0042596) | 3.02106497 |
| 103 | cell migration in hindbrain (GO:0021535) | 3.00961365 |
| 104 | regulation of synaptic transmission (GO:0050804) | 3.00894143 |
| 105 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.00349416 |
| 106 | synaptic transmission (GO:0007268) | 2.99236175 |
| 107 | negative regulation of neurotransmitter transport (GO:0051589) | 2.99028100 |
| 108 | otic vesicle formation (GO:0030916) | 2.95981327 |
| 109 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.95648379 |
| 110 | regulation of dendritic spine development (GO:0060998) | 2.95625258 |
| 111 | regulation of synapse structural plasticity (GO:0051823) | 2.95438524 |
| 112 | negative regulation of axon extension (GO:0030517) | 2.95434202 |
| 113 | axonal fasciculation (GO:0007413) | 2.94371313 |
| 114 | neuronal action potential (GO:0019228) | 2.93508962 |
| 115 | negative regulation of amino acid transport (GO:0051956) | 2.93118604 |
| 116 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.93013614 |
| 117 | neuromuscular synaptic transmission (GO:0007274) | 2.92885575 |
| 118 | dendrite morphogenesis (GO:0048813) | 2.92761313 |
| 119 | regulation of vesicle fusion (GO:0031338) | 2.92410862 |
| 120 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.92099672 |
| 121 | negative regulation of dendrite development (GO:2000171) | 2.91471817 |
| 122 | somite development (GO:0061053) | 2.89838222 |
| 123 | forebrain neuron differentiation (GO:0021879) | 2.88217353 |
| 124 | protein polyglutamylation (GO:0018095) | 2.87978351 |
| 125 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.83515143 |
| 126 | membrane depolarization during action potential (GO:0086010) | 2.82061755 |
| 127 | adult walking behavior (GO:0007628) | 2.79462539 |
| 128 | negative regulation of glial cell differentiation (GO:0045686) | 2.79209696 |
| 129 | C4-dicarboxylate transport (GO:0015740) | 2.74697458 |
| 130 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.74251475 |
| 131 | positive regulation of amino acid transport (GO:0051957) | 2.74104432 |
| 132 | cochlea development (GO:0090102) | 2.74058938 |
| 133 | neuronal stem cell maintenance (GO:0097150) | 2.73065905 |
| 134 | synapse organization (GO:0050808) | 2.71178392 |
| 135 | regulation of collateral sprouting (GO:0048670) | 2.67159429 |
| 136 | positive regulation of action potential (GO:0045760) | 2.67133407 |
| 137 | negative regulation of astrocyte differentiation (GO:0048712) | 2.66747852 |
| 138 | regulation of action potential (GO:0098900) | 2.66641840 |
| 139 | tachykinin receptor signaling pathway (GO:0007217) | 2.66085595 |
| 140 | central nervous system neuron axonogenesis (GO:0021955) | 2.59733423 |
| 141 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.59692847 |
| 142 | prepulse inhibition (GO:0060134) | 2.58856719 |
| 143 | negative regulation of axon guidance (GO:1902668) | 2.58498484 |
| 144 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.56389952 |
| 145 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.55845553 |
| 146 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.55772377 |
| 147 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.52430667 |
| 148 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.52287109 |
| 149 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.51333253 |
| 150 | mitochondrion transport along microtubule (GO:0047497) | 2.51333253 |
| 151 | negative regulation of axonogenesis (GO:0050771) | 2.49735674 |
| 152 | epithelial cilium movement (GO:0003351) | 2.49469055 |
| 153 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.49382617 |
| 154 | adult behavior (GO:0030534) | 2.49245416 |
| 155 | regulation of synapse organization (GO:0050807) | 2.48083039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.97347708 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.93723354 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11073776 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.09249958 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98432679 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.92056269 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.89776536 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57655830 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.49757183 |
| 10 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.47413166 |
| 11 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.44658305 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44080631 |
| 13 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43666717 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.41660811 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.41660811 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.36171126 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35704556 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35523284 |
| 19 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29584797 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.22015722 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21575579 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.20849430 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.18929009 |
| 24 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.16646529 |
| 25 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.10064524 |
| 26 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.98207130 |
| 27 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.96621856 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94864304 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94800763 |
| 30 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.93082375 |
| 31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.90870764 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90816412 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90143949 |
| 34 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87961380 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.87435546 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.87391063 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85683728 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84930728 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.75871979 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74229836 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69435589 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63949962 |
| 43 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.63803426 |
| 44 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.63691465 |
| 45 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60575789 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59377266 |
| 47 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.57336181 |
| 48 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54771897 |
| 49 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51099902 |
| 50 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50570001 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.47527130 |
| 52 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.43257907 |
| 53 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.42560618 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41295516 |
| 55 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39672864 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38188111 |
| 57 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36848463 |
| 58 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.36502828 |
| 59 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.35811985 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34428039 |
| 61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30760118 |
| 62 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.27694458 |
| 63 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.27032101 |
| 64 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.26665507 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26099954 |
| 66 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24887383 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23737420 |
| 68 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21966029 |
| 69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21365718 |
| 70 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.20961969 |
| 71 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19416947 |
| 72 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19407184 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19400509 |
| 74 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16574779 |
| 75 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12552264 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11984269 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11331949 |
| 78 | JUN_21703547_ChIP-Seq_K562_Human | 1.10205067 |
| 79 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09033836 |
| 80 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.08966075 |
| 81 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.08864850 |
| 82 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08639019 |
| 83 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08248208 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07329322 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07109322 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07109322 |
| 87 | AR_19668381_ChIP-Seq_PC3_Human | 1.07021479 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06542124 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05997794 |
| 90 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05459085 |
| 91 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05242969 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04202406 |
| 93 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04145801 |
| 94 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03849398 |
| 95 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03108793 |
| 96 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01646984 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01605059 |
| 98 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01100660 |
| 99 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01097905 |
| 100 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00921795 |
| 101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00860475 |
| 102 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00454682 |
| 103 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00367869 |
| 104 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00033130 |
| 105 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.00006555 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99450572 |
| 107 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98714669 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98230249 |
| 109 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97694703 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97663295 |
| 111 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97241974 |
| 112 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97074287 |
| 113 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97074287 |
| 114 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96822631 |
| 115 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96151653 |
| 116 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.95229352 |
| 117 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.94974642 |
| 118 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94751018 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92367817 |
| 120 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91354951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 6.15036405 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.10045344 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.91837405 |
| 4 | MP0009745_abnormal_behavioral_response | 3.62124885 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.48911801 |
| 6 | MP0004270_analgesia | 3.45705388 |
| 7 | MP0009046_muscle_twitch | 3.34896638 |
| 8 | MP0002064_seizures | 3.32776784 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.27907948 |
| 10 | MP0003136_yellow_coat_color | 3.11432315 |
| 11 | MP0002736_abnormal_nociception_after | 3.03395490 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.95979482 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.75116441 |
| 14 | MP0002272_abnormal_nervous_system | 2.69559106 |
| 15 | MP0001486_abnormal_startle_reflex | 2.52289443 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.50851722 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.40341293 |
| 18 | MP0002067_abnormal_sensory_capabilities | 2.28138323 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.26934691 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.26627398 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.20968836 |
| 22 | MP0003879_abnormal_hair_cell | 2.20432912 |
| 23 | MP0002822_catalepsy | 2.18070487 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.92587514 |
| 25 | MP0003787_abnormal_imprinting | 1.90964338 |
| 26 | MP0001188_hyperpigmentation | 1.90499663 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.84276071 |
| 28 | MP0001984_abnormal_olfaction | 1.81625675 |
| 29 | MP0001529_abnormal_vocalization | 1.79263684 |
| 30 | MP0001970_abnormal_pain_threshold | 1.76495407 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.76127341 |
| 32 | MP0000778_abnormal_nervous_system | 1.74023760 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.71596142 |
| 34 | MP0004924_abnormal_behavior | 1.71596142 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.71401204 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.69294461 |
| 37 | MP0002184_abnormal_innervation | 1.62923160 |
| 38 | MP0004133_heterotaxia | 1.61862638 |
| 39 | MP0008569_lethality_at_weaning | 1.60353487 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.59288353 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.57925663 |
| 42 | MP0004142_abnormal_muscle_tone | 1.48772384 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.45667483 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.45484674 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.43792303 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.41992782 |
| 47 | MP0003329_amyloid_beta_deposits | 1.41900160 |
| 48 | MP0001905_abnormal_dopamine_level | 1.41431213 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.36224984 |
| 50 | MP0005171_absent_coat_pigmentation | 1.35054243 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.34940582 |
| 52 | MP0004742_abnormal_vestibular_system | 1.33603661 |
| 53 | MP0003122_maternal_imprinting | 1.33516628 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.32792926 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.31184342 |
| 56 | MP0003633_abnormal_nervous_system | 1.28762832 |
| 57 | MP0000955_abnormal_spinal_cord | 1.26854065 |
| 58 | MP0002751_abnormal_autonomic_nervous | 1.26479208 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 1.25213035 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.22256103 |
| 61 | MP0001986_abnormal_taste_sensitivity | 1.21288919 |
| 62 | MP0000566_synostosis | 1.21005550 |
| 63 | MP0002928_abnormal_bile_duct | 1.18103647 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 1.13611764 |
| 65 | MP0001963_abnormal_hearing_physiology | 1.11123548 |
| 66 | MP0003011_delayed_dark_adaptation | 1.09716274 |
| 67 | MP0003631_nervous_system_phenotype | 1.09388099 |
| 68 | MP0000049_abnormal_middle_ear | 1.06587638 |
| 69 | MP0002102_abnormal_ear_morphology | 1.06064147 |
| 70 | MP0002938_white_spotting | 1.04488963 |
| 71 | MP0004885_abnormal_endolymph | 1.02444218 |
| 72 | MP0003861_abnormal_nervous_system | 1.01866274 |
| 73 | MP0005187_abnormal_penis_morphology | 0.99825698 |
| 74 | MP0005195_abnormal_posterior_eye | 0.99191996 |
| 75 | MP0008004_abnormal_stomach_pH | 0.98947731 |
| 76 | MP0002229_neurodegeneration | 0.98189607 |
| 77 | MP0002152_abnormal_brain_morphology | 0.97670137 |
| 78 | MP0003283_abnormal_digestive_organ | 0.96818448 |
| 79 | MP0000751_myopathy | 0.96531239 |
| 80 | MP0003183_abnormal_peptide_metabolism | 0.96089965 |
| 81 | MP0008872_abnormal_physiological_respon | 0.94227803 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.93390655 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.91341945 |
| 84 | MP0003938_abnormal_ear_development | 0.90758061 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 0.89696412 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.88420719 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.87821113 |
| 88 | MP0003119_abnormal_digestive_system | 0.87520931 |
| 89 | MP0004085_abnormal_heartbeat | 0.86714419 |
| 90 | MP0008874_decreased_physiological_sensi | 0.85271300 |
| 91 | MP0003123_paternal_imprinting | 0.84982281 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.84503026 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.84417405 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.84203247 |
| 95 | MP0001664_abnormal_digestion | 0.82225748 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.81638698 |
| 97 | MP0001293_anophthalmia | 0.80645821 |
| 98 | MP0003937_abnormal_limbs/digits/tail_de | 0.80576712 |
| 99 | MP0004858_abnormal_nervous_system | 0.79268924 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.77751277 |
| 101 | MP0008789_abnormal_olfactory_epithelium | 0.77675937 |
| 102 | MP0002752_abnormal_somatic_nervous | 0.77016609 |
| 103 | MP0003755_abnormal_palate_morphology | 0.76416158 |
| 104 | MP0000026_abnormal_inner_ear | 0.75693902 |
| 105 | MP0001299_abnormal_eye_distance/ | 0.74889663 |
| 106 | MP0008877_abnormal_DNA_methylation | 0.74655058 |
| 107 | MP0009250_abnormal_appendicular_skeleto | 0.73145870 |
| 108 | MP0005409_darkened_coat_color | 0.71727792 |
| 109 | MP0005174_abnormal_tail_pigmentation | 0.71342607 |
| 110 | MP0000920_abnormal_myelination | 0.70940473 |
| 111 | MP0004134_abnormal_chest_morphology | 0.70478290 |
| 112 | MP0005535_abnormal_body_temperature | 0.70358157 |
| 113 | MP0002282_abnormal_trachea_morphology | 0.70308648 |
| 114 | MP0000534_abnormal_ureter_morphology | 0.69508839 |
| 115 | MP0004484_altered_response_of | 0.69410644 |
| 116 | MP0004043_abnormal_pH_regulation | 0.67960297 |
| 117 | MP0003632_abnormal_nervous_system | 0.67114205 |
| 118 | MP0003634_abnormal_glial_cell | 0.65813707 |
| 119 | MP0001177_atelectasis | 0.64020909 |
| 120 | MP0001943_abnormal_respiration | 0.63978487 |
| 121 | MP0003690_abnormal_glial_cell | 0.59597413 |
| 122 | MP0002090_abnormal_vision | 0.58787090 |
| 123 | MP0005499_abnormal_olfactory_system | 0.57120195 |
| 124 | MP0005394_taste/olfaction_phenotype | 0.57120195 |
| 125 | MP0002082_postnatal_lethality | 0.55169340 |
| 126 | MP0010770_preweaning_lethality | 0.55169340 |
| 127 | MP0000604_amyloidosis | 0.53300836 |
| 128 | MP0010769_abnormal_survival | 0.51936934 |
| 129 | MP0005623_abnormal_meninges_morphology | 0.51416874 |
| 130 | MP0010768_mortality/aging | 0.49386316 |
| 131 | MP0004233_abnormal_muscle_weight | 0.49112598 |
| 132 | MP0003121_genomic_imprinting | 0.48460112 |
| 133 | MP0004036_abnormal_muscle_relaxation | 0.48360203 |
| 134 | MP0005253_abnormal_eye_physiology | 0.46642065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.08507006 |
| 2 | Epileptic encephalopathy (HP:0200134) | 7.09170155 |
| 3 | Hyperventilation (HP:0002883) | 6.61543120 |
| 4 | Atonic seizures (HP:0010819) | 6.39762236 |
| 5 | Focal seizures (HP:0007359) | 5.63946437 |
| 6 | Febrile seizures (HP:0002373) | 5.40556936 |
| 7 | Absence seizures (HP:0002121) | 4.90056671 |
| 8 | Septo-optic dysplasia (HP:0100842) | 4.88906025 |
| 9 | Dialeptic seizures (HP:0011146) | 4.66875141 |
| 10 | Myokymia (HP:0002411) | 4.55898500 |
| 11 | Broad-based gait (HP:0002136) | 4.46811273 |
| 12 | Visual hallucinations (HP:0002367) | 3.85863172 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.81159146 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.54065825 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.52916956 |
| 16 | True hermaphroditism (HP:0010459) | 3.43737290 |
| 17 | Optic nerve hypoplasia (HP:0000609) | 3.40816603 |
| 18 | Protruding tongue (HP:0010808) | 3.36844547 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 3.28219206 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 3.28219206 |
| 21 | Poor eye contact (HP:0000817) | 3.23971814 |
| 22 | Nephronophthisis (HP:0000090) | 3.15931062 |
| 23 | Drooling (HP:0002307) | 3.13209374 |
| 24 | Excessive salivation (HP:0003781) | 3.13209374 |
| 25 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 3.01945790 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 2.97459703 |
| 27 | Pancreatic fibrosis (HP:0100732) | 2.92595268 |
| 28 | Dysdiadochokinesis (HP:0002075) | 2.91924129 |
| 29 | Inability to walk (HP:0002540) | 2.91922416 |
| 30 | Abnormal eating behavior (HP:0100738) | 2.91886995 |
| 31 | Amblyopia (HP:0000646) | 2.91880248 |
| 32 | Abnormal hair whorl (HP:0010721) | 2.90646007 |
| 33 | Hemiplegia (HP:0002301) | 2.86672056 |
| 34 | Pancreatic cysts (HP:0001737) | 2.85906478 |
| 35 | Abnormal social behavior (HP:0012433) | 2.84981508 |
| 36 | Impaired social interactions (HP:0000735) | 2.84981508 |
| 37 | Absent septum pellucidum (HP:0001331) | 2.82568763 |
| 38 | Sensory axonal neuropathy (HP:0003390) | 2.80966018 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.78724922 |
| 40 | Truncal ataxia (HP:0002078) | 2.75490864 |
| 41 | Gait imbalance (HP:0002141) | 2.71404047 |
| 42 | Dysmetric saccades (HP:0000641) | 2.68513634 |
| 43 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.66659966 |
| 44 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.66659966 |
| 45 | Polyphagia (HP:0002591) | 2.64990565 |
| 46 | Hyperthyroidism (HP:0000836) | 2.59785448 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 2.59327332 |
| 48 | Absent speech (HP:0001344) | 2.58941642 |
| 49 | Termporal pattern (HP:0011008) | 2.58064206 |
| 50 | Insidious onset (HP:0003587) | 2.58064206 |
| 51 | Ulnar claw (HP:0001178) | 2.57623794 |
| 52 | Megalencephaly (HP:0001355) | 2.56069871 |
| 53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54432569 |
| 54 | Blue irides (HP:0000635) | 2.54027751 |
| 55 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.52694318 |
| 56 | Medial flaring of the eyebrow (HP:0010747) | 2.49284897 |
| 57 | Fetal akinesia sequence (HP:0001989) | 2.49016052 |
| 58 | Pheochromocytoma (HP:0002666) | 2.46887672 |
| 59 | Dysmetria (HP:0001310) | 2.45358198 |
| 60 | Pendular nystagmus (HP:0012043) | 2.44639936 |
| 61 | Congenital primary aphakia (HP:0007707) | 2.44627792 |
| 62 | Abnormality of the corticospinal tract (HP:0002492) | 2.44142458 |
| 63 | Scanning speech (HP:0002168) | 2.43252616 |
| 64 | Nephrogenic diabetes insipidus (HP:0009806) | 2.38009976 |
| 65 | Progressive inability to walk (HP:0002505) | 2.36200716 |
| 66 | Anxiety (HP:0000739) | 2.34980679 |
| 67 | Depression (HP:0000716) | 2.34341033 |
| 68 | Agitation (HP:0000713) | 2.34140823 |
| 69 | Poor suck (HP:0002033) | 2.33479659 |
| 70 | Impaired smooth pursuit (HP:0007772) | 2.33035641 |
| 71 | Increased serum pyruvate (HP:0003542) | 2.29943724 |
| 72 | Abnormality of glycolysis (HP:0004366) | 2.29943724 |
| 73 | Hypsarrhythmia (HP:0002521) | 2.29023796 |
| 74 | Type II lissencephaly (HP:0007260) | 2.28007518 |
| 75 | Neuroendocrine neoplasm (HP:0100634) | 2.26788169 |
| 76 | Action tremor (HP:0002345) | 2.26205483 |
| 77 | Lissencephaly (HP:0001339) | 2.25781239 |
| 78 | Abnormality of the septum pellucidum (HP:0007375) | 2.24714025 |
| 79 | Oligodactyly (hands) (HP:0001180) | 2.22542636 |
| 80 | Sclerocornea (HP:0000647) | 2.17610858 |
| 81 | Retinal dysplasia (HP:0007973) | 2.17422116 |
| 82 | Stereotypic behavior (HP:0000733) | 2.17346704 |
| 83 | Spastic gait (HP:0002064) | 2.16802623 |
| 84 | Thickened helices (HP:0000391) | 2.16280959 |
| 85 | Esophageal atresia (HP:0002032) | 2.15060928 |
| 86 | Short 4th metacarpal (HP:0010044) | 2.14814023 |
| 87 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.14814023 |
| 88 | Impaired vibratory sensation (HP:0002495) | 2.14230502 |
| 89 | Growth hormone deficiency (HP:0000824) | 2.13740064 |
| 90 | Anophthalmia (HP:0000528) | 2.13600545 |
| 91 | Ankle clonus (HP:0011448) | 2.13252584 |
| 92 | Abnormal ciliary motility (HP:0012262) | 2.11917577 |
| 93 | Abnormality of salivation (HP:0100755) | 2.10529595 |
| 94 | Chorioretinal atrophy (HP:0000533) | 2.10462533 |
| 95 | Abnormality of the labia minora (HP:0012880) | 2.10427855 |
| 96 | Specific learning disability (HP:0001328) | 2.08516194 |
| 97 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.07997870 |
| 98 | Absent/shortened dynein arms (HP:0200106) | 2.07997870 |
| 99 | Status epilepticus (HP:0002133) | 2.07691489 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 2.05841832 |
| 101 | Pachygyria (HP:0001302) | 2.04086726 |
| 102 | Abolished electroretinogram (ERG) (HP:0000550) | 2.03256508 |
| 103 | Diplopia (HP:0000651) | 2.02653368 |
| 104 | Abnormality of binocular vision (HP:0011514) | 2.02653368 |
| 105 | Hemiparesis (HP:0001269) | 2.02550888 |
| 106 | Hyperglycinemia (HP:0002154) | 2.01988250 |
| 107 | Urinary urgency (HP:0000012) | 2.00252949 |
| 108 | Thyroid-stimulating hormone excess (HP:0002925) | 2.00121596 |
| 109 | Acute necrotizing encephalopathy (HP:0006965) | 1.98643637 |
| 110 | Limb dystonia (HP:0002451) | 1.98470133 |
| 111 | Bradykinesia (HP:0002067) | 1.98323819 |
| 112 | Rib fusion (HP:0000902) | 1.97698655 |
| 113 | Cystic liver disease (HP:0006706) | 1.97549088 |
| 114 | Akinesia (HP:0002304) | 1.96974903 |
| 115 | Hepatoblastoma (HP:0002884) | 1.96439537 |
| 116 | Genetic anticipation (HP:0003743) | 1.96015220 |
| 117 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95986853 |
| 118 | Chronic hepatic failure (HP:0100626) | 1.95155507 |
| 119 | Abnormality of the 4th metacarpal (HP:0010012) | 1.95032671 |
| 120 | Narrow nasal bridge (HP:0000446) | 1.94325042 |
| 121 | Resting tremor (HP:0002322) | 1.93969564 |
| 122 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.90892196 |
| 123 | Congenital stationary night blindness (HP:0007642) | 1.90871778 |
| 124 | Incomplete penetrance (HP:0003829) | 1.90210014 |
| 125 | Postural instability (HP:0002172) | 1.89953038 |
| 126 | Vaginal atresia (HP:0000148) | 1.89226251 |
| 127 | Genital tract atresia (HP:0001827) | 1.89123834 |
| 128 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.88639094 |
| 129 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.87847558 |
| 130 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.87442084 |
| 131 | Lower limb muscle weakness (HP:0007340) | 1.86711131 |
| 132 | Postaxial hand polydactyly (HP:0001162) | 1.86669174 |
| 133 | Abnormality of the lower motor neuron (HP:0002366) | 1.86243425 |
| 134 | Failure to thrive in infancy (HP:0001531) | 1.85776429 |
| 135 | Progressive macrocephaly (HP:0004481) | 1.85594054 |
| 136 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.85309506 |
| 137 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.85309506 |
| 138 | Fair hair (HP:0002286) | 1.85161164 |
| 139 | Poor coordination (HP:0002370) | 1.84983530 |
| 140 | Gastrointestinal atresia (HP:0002589) | 1.84982023 |
| 141 | Anencephaly (HP:0002323) | 1.84249995 |
| 142 | Oligomenorrhea (HP:0000876) | 1.84241351 |
| 143 | Supranuclear gaze palsy (HP:0000605) | 1.83912865 |
| 144 | Torticollis (HP:0000473) | 1.82924942 |
| 145 | Gait ataxia (HP:0002066) | 1.81792391 |
| 146 | Gastroesophageal reflux (HP:0002020) | 1.81641784 |
| 147 | Bilateral microphthalmos (HP:0007633) | 1.80430016 |
| 148 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.79520428 |
| 149 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.78504297 |
| 150 | Congenital, generalized hypertrichosis (HP:0004540) | 1.76737451 |
| 151 | Cutaneous finger syndactyly (HP:0010554) | 1.76202336 |
| 152 | Occipital encephalocele (HP:0002085) | 1.74334086 |
| 153 | Spastic tetraplegia (HP:0002510) | 1.72813778 |
| 154 | Maternal diabetes (HP:0009800) | 1.71809223 |
| 155 | Renal hypoplasia (HP:0000089) | 1.71244697 |
| 156 | Short tibia (HP:0005736) | 1.69139802 |
| 157 | Abnormality of the diencephalon (HP:0010662) | 1.66909196 |
| 158 | Midline defect of the nose (HP:0004122) | 1.66387998 |
| 159 | Hemivertebrae (HP:0002937) | 1.65968108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 7.77295277 |
| 2 | EPHA4 | 3.98918813 |
| 3 | NTRK3 | 3.38686411 |
| 4 | DAPK2 | 3.08306950 |
| 5 | CCNB1 | 3.02574381 |
| 6 | CDK19 | 2.85482504 |
| 7 | MAP2K7 | 2.79668931 |
| 8 | MAP3K4 | 2.71105439 |
| 9 | MAPK15 | 2.60770511 |
| 10 | MAP3K12 | 2.42128341 |
| 11 | DYRK2 | 2.37713827 |
| 12 | AKT3 | 2.33797816 |
| 13 | PRPF4B | 2.27704948 |
| 14 | PLK2 | 2.27595006 |
| 15 | PINK1 | 2.24085738 |
| 16 | DAPK1 | 2.19346265 |
| 17 | FRK | 1.98220860 |
| 18 | OXSR1 | 1.96244890 |
| 19 | MAP3K9 | 1.92320719 |
| 20 | BMPR1B | 1.89824587 |
| 21 | MARK1 | 1.70081883 |
| 22 | MINK1 | 1.61547696 |
| 23 | MAP2K4 | 1.56519049 |
| 24 | WEE1 | 1.42868771 |
| 25 | EPHB2 | 1.39841098 |
| 26 | TNIK | 1.39827814 |
| 27 | RIPK4 | 1.37015688 |
| 28 | NTRK2 | 1.35211748 |
| 29 | CAMKK2 | 1.31224102 |
| 30 | MAPK13 | 1.28617128 |
| 31 | PAK6 | 1.26769049 |
| 32 | PAK3 | 1.20990447 |
| 33 | WNK4 | 1.20238867 |
| 34 | TSSK6 | 1.19424652 |
| 35 | GRK5 | 1.16279941 |
| 36 | CDK5 | 1.15039086 |
| 37 | SIK3 | 1.14834722 |
| 38 | MAP4K2 | 1.14599900 |
| 39 | SGK223 | 1.13387559 |
| 40 | SGK494 | 1.13387559 |
| 41 | CAMK2A | 1.11410599 |
| 42 | PNCK | 1.09073560 |
| 43 | PRKCG | 1.09065229 |
| 44 | GRK1 | 1.07693761 |
| 45 | SGK2 | 1.06509964 |
| 46 | KSR1 | 1.05167631 |
| 47 | CAMK2B | 1.00426085 |
| 48 | MKNK2 | 0.99750596 |
| 49 | PTK2B | 0.98270896 |
| 50 | CAMK1G | 0.95409995 |
| 51 | CAMKK1 | 0.93591844 |
| 52 | ARAF | 0.91532524 |
| 53 | NME1 | 0.90658406 |
| 54 | BMPR2 | 0.89499443 |
| 55 | BRAF | 0.89005330 |
| 56 | PDK4 | 0.88688336 |
| 57 | PDK3 | 0.88688336 |
| 58 | CDK18 | 0.80428973 |
| 59 | FES | 0.79289417 |
| 60 | CSNK1G1 | 0.78813018 |
| 61 | CSNK1G3 | 0.78182934 |
| 62 | FGFR2 | 0.77503418 |
| 63 | BCR | 0.77060769 |
| 64 | MAPK7 | 0.74188236 |
| 65 | CDK15 | 0.73781608 |
| 66 | DAPK3 | 0.72656731 |
| 67 | CDK14 | 0.72179145 |
| 68 | PRKCE | 0.71830709 |
| 69 | EPHA3 | 0.71791967 |
| 70 | VRK1 | 0.70954125 |
| 71 | NTRK1 | 0.70809657 |
| 72 | KSR2 | 0.70704894 |
| 73 | FGR | 0.70319341 |
| 74 | CSNK1A1L | 0.68032376 |
| 75 | CAMK1D | 0.67888039 |
| 76 | DYRK3 | 0.67264629 |
| 77 | SGK3 | 0.65006011 |
| 78 | CDK3 | 0.63421668 |
| 79 | ERBB2 | 0.62696182 |
| 80 | SGK1 | 0.62405771 |
| 81 | CDK11A | 0.62281629 |
| 82 | UHMK1 | 0.61796486 |
| 83 | PRKCZ | 0.61451072 |
| 84 | MAPK12 | 0.60710635 |
| 85 | SIK2 | 0.60227735 |
| 86 | YES1 | 0.59335847 |
| 87 | STK16 | 0.56945845 |
| 88 | TAOK1 | 0.56182052 |
| 89 | CAMK1 | 0.55231446 |
| 90 | CAMK2D | 0.53622967 |
| 91 | DYRK1A | 0.53558988 |
| 92 | PHKG1 | 0.51878748 |
| 93 | PHKG2 | 0.51878748 |
| 94 | TGFBR1 | 0.51297909 |
| 95 | TAOK3 | 0.49898003 |
| 96 | PDK2 | 0.49825477 |
| 97 | STK11 | 0.49656099 |
| 98 | NUAK1 | 0.48389066 |
| 99 | ADRBK1 | 0.48079591 |
| 100 | STK39 | 0.47882613 |
| 101 | TNK2 | 0.47712504 |
| 102 | MAP3K13 | 0.47647673 |
| 103 | ADRBK2 | 0.46636250 |
| 104 | GRK7 | 0.45293711 |
| 105 | TRIM28 | 0.43172205 |
| 106 | PKN1 | 0.42665307 |
| 107 | CSNK1E | 0.42600973 |
| 108 | CAMK2G | 0.42472830 |
| 109 | ROCK1 | 0.42272354 |
| 110 | TLK1 | 0.41735549 |
| 111 | ROCK2 | 0.41248636 |
| 112 | NEK6 | 0.40699445 |
| 113 | WNK3 | 0.39584557 |
| 114 | PDPK1 | 0.38489326 |
| 115 | CSNK1A1 | 0.38395569 |
| 116 | MAP2K2 | 0.38091943 |
| 117 | MUSK | 0.36440416 |
| 118 | CAMK4 | 0.36439959 |
| 119 | CSNK1G2 | 0.36392863 |
| 120 | MYLK | 0.36023527 |
| 121 | PDK1 | 0.35936663 |
| 122 | TYRO3 | 0.35762973 |
| 123 | STK38L | 0.35144203 |
| 124 | CSNK1D | 0.34293616 |
| 125 | PIK3CA | 0.33639275 |
| 126 | RAF1 | 0.33579099 |
| 127 | PRKACA | 0.32941462 |
| 128 | INSRR | 0.32616510 |
| 129 | PRKCH | 0.31347240 |
| 130 | DYRK1B | 0.30925187 |
| 131 | ZAK | 0.30855457 |
| 132 | MAP3K2 | 0.30318731 |
| 133 | RPS6KA3 | 0.30302859 |
| 134 | CDK8 | 0.29358492 |
| 135 | PRKG1 | 0.27966315 |
| 136 | FER | 0.27913368 |
| 137 | TIE1 | 0.27558740 |
| 138 | FYN | 0.27253755 |
| 139 | MARK2 | 0.26550115 |
| 140 | PRKCA | 0.26025320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.61932786 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.12256863 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.17059476 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.02852170 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.79524929 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70608880 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.62952946 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.55194483 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.54743746 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.51395383 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47679677 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07249801 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.05870241 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.88571364 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.88025945 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.87045533 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.86891193 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.86526766 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.70847158 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60236312 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59072493 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58912287 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.57234995 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51674447 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.50372142 |
| 26 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.49773123 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46821751 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45576525 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45250731 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.42673672 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.42113309 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38194750 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37847775 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.37485785 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.35646646 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31260744 |
| 37 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.28862253 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23593215 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 1.22203276 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19583637 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17062463 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.16785795 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10020695 |
| 44 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.06337440 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05893433 |
| 46 | * Axon guidance_Homo sapiens_hsa04360 | 1.05696484 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04534370 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04337752 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02774961 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01842849 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01459950 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00331106 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97699749 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96567408 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.96136549 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93867570 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93372389 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92911187 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92544070 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.89855668 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86956837 |
| 62 | Ribosome_Homo sapiens_hsa03010 | 0.86053035 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84163701 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80189297 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79607458 |
| 66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.79071876 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78139638 |
| 68 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.77347545 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77010853 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.75727156 |
| 71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75202420 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.74937268 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74515562 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73048453 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70862258 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66927764 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65417641 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65387379 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64814466 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.63518919 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61241427 |
| 82 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60816121 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60267779 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58834408 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56262937 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55321187 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55020152 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.54065411 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53481240 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51764054 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51268580 |
| 92 | RNA polymerase_Homo sapiens_hsa03020 | 0.50479457 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49650846 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48862354 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48371709 |
| 96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48119636 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48112197 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46277099 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45187274 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45112907 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43946387 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43499376 |
| 103 | Peroxisome_Homo sapiens_hsa04146 | 0.43289057 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42447610 |
| 105 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41514329 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40777194 |
| 107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40306026 |
| 108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39100240 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.38395652 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37174680 |
| 111 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37092676 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36597359 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36081036 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35619271 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34528877 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33765637 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32507890 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32354021 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29692865 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28365173 |
| 121 | Melanoma_Homo sapiens_hsa05218 | 0.28121761 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27510900 |
| 123 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.27245134 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26981833 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.21291409 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20793821 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20109224 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.19674545 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.18349811 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17616589 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.16199856 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14210679 |
| 133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13883402 |

